Process Development for Production of Viral Vaccines and Vectors

Process Development for Production of  Viral Vaccines and Vectors
Product Description

Process Development for API Production, Fill/Finish and Secondary Packaging- Cell line development
- Transfer of customer technologies
-Upstream / Downstream -iCellis Fermenter: development of scalable upstream and downstream technologies for adherent cells with higher yield.Major advantage for development of safe live viral vaccines using non-tumorigenic cell lines
- Formulation Development
- Stability Evaluation
- Process Development for API production- Development and qualification of own seed cell banks for vaccine manufacturing, GMP cell lines Vero and DF-1, Duck cell line (AGE-1)
Contact us for more information

IDT Biologika GmbH

  • DE
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Contract Service
Primary activities
API Producer
Biopharmaceutical
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Packaging & drug delivery
Specifications
  • Supplied from
    Germany; United States

IDT Biologika GmbH

  • DE
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Contract Service
Primary activities
API Producer
Biopharmaceutical
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Packaging & drug delivery

More Products from IDT Biologika GmbH (4)

  • IDT Biologika as a Contract Development and Manufacturing Organization

    Product IDT Biologika as a Contract Development and Manufacturing Organization

    IDT Biologika is an international leader in the contract development and manufacturing of biologics. The company focuses on the customized development and manufacturing of viral vaccines (phases I, II, III), gene therapeutics, immunotherapeutics, oncolytic viruses as well as sterile liquid and lyophiliz...
  • Drug Substance Manufacturing for Viral Vaccines, Gene & Immune Therapeutics, Oncolytic Viruses and Viral Vectors

    Product Drug Substance Manufacturing for Viral Vaccines, Gene & Immune Therapeutics, Oncolytic Viruses and Viral Vectors

    Drug Substance Manufacturing  for pre-clinical, clinical and commercial supply- Validation of aseptic processes
    - Cell and virus banking 
    - Using own seed cell banks: VERO and DF-1, Duck cell line (AGE-1)
    - API production using different TechnologiesMVA Know-How

    IDT Biolo...
  • Sterile Dosage Filling and Lyophilization

    Product Sterile Dosage Filling and Lyophilization

    IDT Biologika GmbH provides a wide range of pharmaceutical services which includes sterile dosage filling in vials and pre-filled syringes. With a facility size of 3,600m2, this integrated pharmaceutical/ biological site houses more than 7 filling lines for the aseptic filling of syringes, vials, ampoules ...
  • Packaging, Quality Control, Storage, Cold Chain

    Product Packaging, Quality Control, Storage, Cold Chain

    Within the contract development and manufacturing, IDT Biologika GmbH provides a wide range of other pharmaceutical services for our clients products, which include-  Labeling & Packaging of vials, prefilled syringes, autoinjectors
    - Serializiation (Track & Trace)
    - Quality Systems
    - ...

IDT Biologika GmbH resources (3)

  • News Are you looking for Drug Substance, Fill&Finish and Packaging capacities?

    We are very proud to extend our facilities in Drug Substance according to BSL 3 and to set up another high-speed filling capacities. Due to our great know-how, commercial excellence, strong partnerships and customer centricity we will push both, innovation and new production capacities for important vaccines against infectious diseases affecting people worldwide.
  • Brochure IDT Biologika Services

    Contract Development and Manufacturing of Vaccines, Viral Vectors for Gene & Immune Therapeutics and Oncolytic Viruses, Virus-like Particles
  • Video About IDT Biologika

    Contract Development and Manufacturing of Vaccines, Viral Vectors for Gene & Immune Therapeutics and Oncolytic Viruses, Virus-like Particles